Development of second- and third-generation bovine immunodeficiency virus-based gene transfer systems
- PMID: 12162812
- DOI: 10.1089/104303402760128522
Development of second- and third-generation bovine immunodeficiency virus-based gene transfer systems
Abstract
Lentivirus-based gene transfer systems have demonstrated their utility in mediating gene transfer to dividing and nondividing cells both in vitro and in vivo. An early-generation gene transfer system developed from bovine immunodeficiency virus (BIV) has been described (Berkowitz et al., J. Virol. 2001;75:3371-3382). In this paper, we describe the development of second-generation (three-plasmid) and third-generation (four-plasmid) BIV-based systems. All accessory genes (vif, vpw, vpy, and tmx) and the regulatory gene tat were deleted or largely truncated from the packaging construct. Furthermore, we split the packaging function into two constructs by expressing Rev in a separate plasmid. Together with our minimal BIV transfer vector construct and a vesicular stomatitis virus G glycoprotein-expressing plasmid, the BIV vectors were generated. The vectors produced by the three- and four-plasmid systems had titers greater than 1 x 10(6) transducing units per milliliter and were fully functional as indicated by their ability to efficiently transduce both dividing and nondividing cells. These results suggest that the accessory genes vif, vpw, vpy, and tmx are dispensable for functional BIV vector development. The modifications made to the packaging constructs improve the safety profile of the vector system. Finally, BIV vectors provide an alternative to human immunodeficiency virus-based gene transfer systems.
Similar articles
-
Mapping of the bovine immunodeficiency virus packaging signal and RRE and incorporation into a minimal gene transfer vector.Virology. 2002 Dec 5;304(1):10-23. doi: 10.1006/viro.2002.1688. Virology. 2002. PMID: 12490399
-
A synthetic Rev-independent bovine immunodeficiency virus-based packaging construct.Hum Gene Ther. 2004 Sep;15(9):865-77. doi: 10.1089/hum.2004.15.865. Hum Gene Ther. 2004. PMID: 15353041
-
Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.Hum Gene Ther. 2001 May 1;12(7):847-57. doi: 10.1089/104303401750148847. Hum Gene Ther. 2001. PMID: 11339901
-
Development of the bovine immunodeficiency-like virus as a model of lentivirus disease.Dev Biol Stand. 1990;72:97-110. Dev Biol Stand. 1990. PMID: 2178134 Review.
-
Lentiviral vectors: optimization of packaging, transduction and gene expression.J Gene Med. 2004 Feb;6 Suppl 1:S125-38. doi: 10.1002/jgm.501. J Gene Med. 2004. PMID: 14978756 Review.
Cited by
-
The contribution of bovines to human health against viral infections.Environ Sci Pollut Res Int. 2021 Sep;28(34):46999-47023. doi: 10.1007/s11356-021-14941-z. Epub 2021 Jul 16. Environ Sci Pollut Res Int. 2021. PMID: 34272669 Free PMC article. Review.
-
Gammaretroviral vectors: biology, technology and application.Viruses. 2011 Jun;3(6):677-713. doi: 10.3390/v3060677. Epub 2011 Jun 3. Viruses. 2011. PMID: 21994751 Free PMC article. Review.
-
Gene Therapy Applications of Non-Human Lentiviral Vectors.Viruses. 2020 Sep 29;12(10):1106. doi: 10.3390/v12101106. Viruses. 2020. PMID: 33003635 Free PMC article. Review.
-
The inside out of lentiviral vectors.Viruses. 2011 Feb;3(2):132-159. doi: 10.3390/v3020132. Epub 2011 Feb 14. Viruses. 2011. PMID: 22049307 Free PMC article. Review.
-
Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion.J Virol. 2005 Apr;79(7):4150-8. doi: 10.1128/JVI.79.7.4150-4158.2005. J Virol. 2005. PMID: 15767416 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources